# Lyell Immunopharma, Inc.: Form 8-K, filed May 28, 2025

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2025-05-28
- Accepted by EDGAR: May 28, 2025, 16:00 ET
- Period: 2025-05-27
- Accession: 0001193125-25-129448
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000119312525129448/d944707d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000119312525129448/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000119312525129448/d944707d8k.htm

Filed May 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-129448. Last ingested by Listed: Nov 5, 2026, 21:15 ET. No prices; not investment advice.